COYA
Coya Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.49 / 10
Netural
Fund-flow analysis shows a good score (7.61/10) with a positive small-cap inflow trend (0.5037), but block and medium/large flows are negative, indicating institutional hesitation. Analyst coverage is limited to two providers, both issuing Strong Buy ratings, yet their historical win rates are low (25-31.6%), tempering conviction. The neutral sentiment score (5.49/10) reflects this balance between optimistic ratings and mixed flow dynamics.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-21
InstitutionD. Boral Capital
Times predicted19
Historical Win Rate31.6%
What is the analyst consensus for COYA?
- COYA holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.49/10 (Netural).
